Healthcare Markets
Healthcare Markets
Encouraging Competition and Efficiency
Our researchers explore strategies for a patient-centered marketplace that lowers medical costs while expanding access to quality care.
Featured White Paper
U.S. Consumers Overpay for Generic Drugs
Tactics used by intermediaries in the pharmaceutical distribution system, including pharmacy benefit managers (PBMs) and insurers, are costing patients, employers and the government billions for what should be inexpensive medicines.
Experts: Erin Trish, Karen Van Nuys
Top Healthcare Markets Stories View All
Perspective
Assessing the Case Against Direct-to-Consumer Drug Advertisements
Featured Experts: Neeraj Sood
In The News View All
NPR
Joyce interviewed about White House deal lowering prices on anti-obesity medications
Featured Experts: Geoffrey Joyce
NBC News
Duffy explains how people can research payment options before receiving medical care
Featured Experts: Erin L. Duffy
The New York Times
Employers face a growing challenge in managing the costs of specialty drugs, Ginsburg says
Featured Experts: Paul Ginsburg
Medscape
Ginsburg explains the need to reform Medicare’s process for setting physician payments
Featured Experts: Paul Ginsburg
National Academy of Medicine
Goldman examines the impact of the White House’s Pfizer deal and the need for rational drug pricing
Featured Experts: Dana Goldman
Related Subtopics
Competition is essential for a properly functioning marketplace, but industry consolidation, insurance complexity and other factors are impeding healthcare consumers from the benefits of good commerce. Our experts explore ways to remove those obstacles to efficiency, while also promoting optimal care.
Team View All Healthcare Markets Experts
